Keyphrases
HIV Care
100%
Buprenorphine-naloxone
100%
Drug Treatment
42%
Addiction Treatment
42%
Buprenorphine
42%
Policy Barriers
42%
AIDS/HIV
28%
People Living with HIV (PLHIV)
28%
Healthcare Settings
28%
Opioid Dependence
28%
Substance Abuse
14%
Politicians
14%
Potential Gains
14%
Researcher-practitioner
14%
Special Populations
14%
Pharmacological Treatment
14%
Policy Program
14%
Training Issues
14%
Medical Systems
14%
Medical Services
14%
Office-based
14%
Barriers to Integration
14%
Conceptual Differences
14%
Workforce Issues
14%
Treatment Skills
14%
Reimbursement Mechanisms
14%
Physician Training
14%
Support Initiatives
14%
Cross-training
14%
Full Integration
14%
Addiction Medicine
14%
Financing Policy
14%
HIV Medicine
14%
Medicine Drugs
14%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Buprenorphine Plus Naloxone
100%
Drug Therapy
50%
Addictive Behavior
37%
Buprenorphine
37%
HIV/AIDS
25%
Substance Abuse
12%
Medicine
12%
Medical Care
12%
Opiate
12%
Medical Care Service
12%
Opioid Dependence
12%
Cross-Training
12%
Addiction Medicine
12%
Workforce Issue
12%
Psychology
Policy Implication
100%
Naloxone
100%
Substance Abuse
50%
Practitioners
50%
Pharmacological Treatment
50%
Workforce Issue
50%
Social Sciences
Human Immunodeficiency Virus
100%
AIDS
25%
Substance Abuse
12%
Special Population
12%
Medical Care Service
12%
Workforce Issue
12%
Economics, Econometrics and Finance